Filter News
Area of Research
- (-) National Security (8)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (1)
- Biology and Environment (14)
- Clean Energy (35)
- Computational Engineering (1)
- Computer Science (2)
- Energy Frontier Research Centers (1)
- Fusion and Fission (10)
- Fusion Energy (2)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (34)
- Materials for Computing (5)
- Neutron Science (16)
- Quantum information Science (1)
- Supercomputing (24)
News Topics
- (-) Biomedical (2)
- (-) Fusion (2)
- (-) Grid (1)
- (-) Machine Learning (4)
- (-) Space Exploration (2)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (3)
- Artificial Intelligence (6)
- Bioenergy (2)
- Biology (2)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (9)
- Cybersecurity (9)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Exascale Computing (1)
- Frontier (1)
- High-Performance Computing (1)
- Isotopes (2)
- Materials (1)
- Materials Science (2)
- National Security (11)
- Neutron Science (3)
- Nuclear Energy (9)
- Partnerships (4)
- Physics (2)
- Security (5)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.